Reversible Irreversible Agents
Reversible Irreversible Agents - Related Videos
01:14
Reversible and Irreversible Processes
0 Views •
2023
The thermodynamic processes can be classified into reversible and irreversible processes. The processes that can be restored to their initial state are called reversible processes. It is only possible if the process is in quasi-static equilibrium, i.e., it takes place in infinitesimally small steps, and the system remains at equilibrium However, these are ideal processes and do not occur naturally. An ideal system undergoing a reversible process is always in thermodynamic equilibrium within...
14:05
A Murine Model of Irreversible and Reversible Unilateral Ureteric Obstruction
0 Views •
Cited by 47 •
2014
The murine model of irreversible unilateral ureteric obstruction (UUO) is presented together with the model of reversible UUO in which the ureteric obstruction is relieved by anastomosis of the severed ureter into the bladder. These models enable the study of renal inflammation and scarring as well as tissue remodeling.
03:50
Irreversible Electroporation: A Technique for Ablating Pancreatic Tumor in Mouse
0 Views •
2023
This video describes the procedure for performing irreversible electroporation (IRE) for non-thermal ablation of pancreatic tumors in mice. Both subcutaneous (SQ) and orthotopic tumors can be successfully treated with IRE in a highly controlled setting, facilitating various studies post-procedure.
07:18
High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing
0 Views •
2019
A high throughput protocol for functional assessment of HIV efficient reactivation and clearance of latent proviruses is described and applied by testing the impact of interventions on HIV transcription and splicing. Representative results of the effect of latency reversing agents on LTR-driven transcription and splicing are provided.
11:27
Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging
0 Views •
Cited by 5 •
2016
This protocol describes the preparation and characterization of a dendrimeric magnetic resonance imaging (MRI) contrast agent that carries cyclen-based macrocyclic chelates coordinating paramagnetic gadolinium ions. In a series of MRI experiments in vitro, this agent produced an amplified MRI signal when compared to the commercially available monomeric analogue.
FAQs
Recovery depends on what happens to the molecular target after exposure. Reversible agents can dissociate as concentrations change, allowing their effects to decline through altered drug-target equilibrium. Irreversible agents may continue modifying the target after exposure ends, so recovery generally requires production of new target molecules. This distinction helps predict effect duration and recovery after adverse exposure.
When an irreversible agent permanently modifies a target, simply changing the agent’s concentration may not restore the original target. Functional recovery therefore depends on generating new target molecules, which can make effects persist longer than expected from exposure alone. This mechanism is important when anticipating prolonged pharmacological actions, dosing requirements, and the management of adverse responses.
The stability of drug-target binding affects how selectively and persistently a compound acts. Reversible interactions provide effects that can change as concentrations vary, whereas exceptionally stable, often covalent interactions can produce lasting target modification. Comparing these properties helps pharmacologists design agents with intended activity while considering persistence, target selectivity, and the possibility of toxicity.
Enzyme inhibition and receptor regulation provide important settings for examining whether target effects can be reversed. A reversible interaction allows pharmacological activity to change as the agent dissociates, while an irreversible interaction can maintain target modification until replacement molecules appear. Studying both contexts helps explain differences in drug duration, recovery, and the regulation of cellular responses.
Researchers should compare onset, persistence, dosing implications, reversibility, and recovery after exposure. These characteristics connect the molecular binding behavior to observable pharmacological outcomes. The comparison can reveal whether an effect is likely to change as concentrations vary or remain until new target molecules are produced, providing a structured basis for interpreting experimental findings and anticipating drug behavior.
The distinction becomes especially important when an adverse response may outlast the period of exposure. Reversible effects can decline as concentrations change, whereas irreversible target modification may persist until new target molecules are produced. Recognizing this difference helps pharmacologists anticipate the duration of toxicity and consider whether recovery is likely to follow concentration changes or require target replacement.
Classifying compounds by reversibility helps connect molecular behavior with practical decisions in pharmacology. It informs expectations about dosing, persistence, recovery, enzyme inhibition, receptor regulation, toxicity, and therapeutic selectivity. Researchers can use these comparisons during drug development to anticipate how long an effect may last and how readily normal target function may return after treatment or unintended exposure.